Lv3
270 积分 2022-11-06 加入
First-in-Human Phase 0 Study of AB001, a Prostate-Specific Membrane Antigen-Targeted 212Pb Radioligand, in Patients with Metastatic Castration-Resistant Prostate Cancer
10天前
已完结
PDA Technical Report No. 60 (TR 60) Process Validation: A Lifecycle Approach (single user digital version)
18天前
已关闭
ICRP Publication 140: Radiological Protection in Therapy with Radiopharmaceuticals
1个月前
已完结
ICRP Publication 140: Radiological Protection in Therapy with Radiopharmaceuticals
1个月前
已关闭
Realising the potential of radioligand therapy: policy solutions for the barriers to implementation across Europe
2个月前
已完结
Production of Lutetium-177: Process Aspects
4个月前
已完结
皖公网安备34019202002308
